Erbium-Yttrium-Aluminum-Garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs

Woan Ruoh Lee, Shing Chuan Shen, Ibrahim A. Aljuffali, Yi Ching Li, Jia You Fang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. To improve the efficiency of treatment, erbium-yttrium-aluminum-garnet (Er-YAG) laser treatment was conducted to facilitate skin permeation of antialopecia drugs such as minoxidil (MXD), diphencyprone (DPCP), and peptide. In vitro and in vivo percutaneous absorption experiments were carried out by using nude mouse skin and porcine skin as permeation barriers. Fluorescence and confocal microscopies were used to visualize distribution of permeants within the skin. Laser ablation at a depth of 6 and 10 μm enhanced MXD skin accumulation twofold to ninefold depending on the skin barriers selected. DPCP absorption showed less enhancement by laser irradiation as compared with MXD. An ablation depth of 10 μm could increase the peptide flux from zero to 4.99 and 0.33 μg cm-2 h-1 for nude mouse skin and porcine skin, respectively. The laser treatment also promoted drug uptake in the hair follicles, with DPCP demonstrating the greatest enhancement (sixfold compared with the control). The imaging of skin examined by microscopies provided evidence of follicular and intercellular delivery assisted by the Er-YAG laser. Besides the ablative effect of removing the stratum corneum, the laser may interact with sebum to break up the barrier function, increasing the skin delivery of antialopecia drugs. The minimally invasive, well-controlled approach of laser-mediated drug permeation offers a potential way to treat alopecia. This study's findings provide the basis for the first report on laser-assisted delivery of antialopecia drugs.

Original languageEnglish
Pages (from-to)3542-3552
Number of pages11
JournalJournal of Pharmaceutical Sciences
Volume103
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Erbium
Solid-State Lasers
Skin
Pharmaceutical Preparations
Minoxidil
Lasers
Alopecia
Nude Mice
Swine
Sebum
Skin Absorption
Peptides
Hair Follicle
Laser Therapy
Fluorescence Microscopy
Confocal Microscopy
Cornea
Microscopy
Therapeutics

Keywords

  • Absorption
  • Alopecia
  • Diphencyprone
  • Laser
  • Macromolecular drug delivery
  • Minoxidil
  • Peptide
  • Percutaneous
  • Skin

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Medicine(all)

Cite this

Erbium-Yttrium-Aluminum-Garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs. / Lee, Woan Ruoh; Shen, Shing Chuan; Aljuffali, Ibrahim A.; Li, Yi Ching; Fang, Jia You.

In: Journal of Pharmaceutical Sciences, Vol. 103, No. 11, 2014, p. 3542-3552.

Research output: Contribution to journalArticle

@article{7bd152234a6c449e9109f52902144ab3,
title = "Erbium-Yttrium-Aluminum-Garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs",
abstract = "Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. To improve the efficiency of treatment, erbium-yttrium-aluminum-garnet (Er-YAG) laser treatment was conducted to facilitate skin permeation of antialopecia drugs such as minoxidil (MXD), diphencyprone (DPCP), and peptide. In vitro and in vivo percutaneous absorption experiments were carried out by using nude mouse skin and porcine skin as permeation barriers. Fluorescence and confocal microscopies were used to visualize distribution of permeants within the skin. Laser ablation at a depth of 6 and 10 μm enhanced MXD skin accumulation twofold to ninefold depending on the skin barriers selected. DPCP absorption showed less enhancement by laser irradiation as compared with MXD. An ablation depth of 10 μm could increase the peptide flux from zero to 4.99 and 0.33 μg cm-2 h-1 for nude mouse skin and porcine skin, respectively. The laser treatment also promoted drug uptake in the hair follicles, with DPCP demonstrating the greatest enhancement (sixfold compared with the control). The imaging of skin examined by microscopies provided evidence of follicular and intercellular delivery assisted by the Er-YAG laser. Besides the ablative effect of removing the stratum corneum, the laser may interact with sebum to break up the barrier function, increasing the skin delivery of antialopecia drugs. The minimally invasive, well-controlled approach of laser-mediated drug permeation offers a potential way to treat alopecia. This study's findings provide the basis for the first report on laser-assisted delivery of antialopecia drugs.",
keywords = "Absorption, Alopecia, Diphencyprone, Laser, Macromolecular drug delivery, Minoxidil, Peptide, Percutaneous, Skin",
author = "Lee, {Woan Ruoh} and Shen, {Shing Chuan} and Aljuffali, {Ibrahim A.} and Li, {Yi Ching} and Fang, {Jia You}",
year = "2014",
doi = "10.1002/jps.24143",
language = "English",
volume = "103",
pages = "3542--3552",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Erbium-Yttrium-Aluminum-Garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs

AU - Lee, Woan Ruoh

AU - Shen, Shing Chuan

AU - Aljuffali, Ibrahim A.

AU - Li, Yi Ching

AU - Fang, Jia You

PY - 2014

Y1 - 2014

N2 - Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. To improve the efficiency of treatment, erbium-yttrium-aluminum-garnet (Er-YAG) laser treatment was conducted to facilitate skin permeation of antialopecia drugs such as minoxidil (MXD), diphencyprone (DPCP), and peptide. In vitro and in vivo percutaneous absorption experiments were carried out by using nude mouse skin and porcine skin as permeation barriers. Fluorescence and confocal microscopies were used to visualize distribution of permeants within the skin. Laser ablation at a depth of 6 and 10 μm enhanced MXD skin accumulation twofold to ninefold depending on the skin barriers selected. DPCP absorption showed less enhancement by laser irradiation as compared with MXD. An ablation depth of 10 μm could increase the peptide flux from zero to 4.99 and 0.33 μg cm-2 h-1 for nude mouse skin and porcine skin, respectively. The laser treatment also promoted drug uptake in the hair follicles, with DPCP demonstrating the greatest enhancement (sixfold compared with the control). The imaging of skin examined by microscopies provided evidence of follicular and intercellular delivery assisted by the Er-YAG laser. Besides the ablative effect of removing the stratum corneum, the laser may interact with sebum to break up the barrier function, increasing the skin delivery of antialopecia drugs. The minimally invasive, well-controlled approach of laser-mediated drug permeation offers a potential way to treat alopecia. This study's findings provide the basis for the first report on laser-assisted delivery of antialopecia drugs.

AB - Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. To improve the efficiency of treatment, erbium-yttrium-aluminum-garnet (Er-YAG) laser treatment was conducted to facilitate skin permeation of antialopecia drugs such as minoxidil (MXD), diphencyprone (DPCP), and peptide. In vitro and in vivo percutaneous absorption experiments were carried out by using nude mouse skin and porcine skin as permeation barriers. Fluorescence and confocal microscopies were used to visualize distribution of permeants within the skin. Laser ablation at a depth of 6 and 10 μm enhanced MXD skin accumulation twofold to ninefold depending on the skin barriers selected. DPCP absorption showed less enhancement by laser irradiation as compared with MXD. An ablation depth of 10 μm could increase the peptide flux from zero to 4.99 and 0.33 μg cm-2 h-1 for nude mouse skin and porcine skin, respectively. The laser treatment also promoted drug uptake in the hair follicles, with DPCP demonstrating the greatest enhancement (sixfold compared with the control). The imaging of skin examined by microscopies provided evidence of follicular and intercellular delivery assisted by the Er-YAG laser. Besides the ablative effect of removing the stratum corneum, the laser may interact with sebum to break up the barrier function, increasing the skin delivery of antialopecia drugs. The minimally invasive, well-controlled approach of laser-mediated drug permeation offers a potential way to treat alopecia. This study's findings provide the basis for the first report on laser-assisted delivery of antialopecia drugs.

KW - Absorption

KW - Alopecia

KW - Diphencyprone

KW - Laser

KW - Macromolecular drug delivery

KW - Minoxidil

KW - Peptide

KW - Percutaneous

KW - Skin

UR - http://www.scopus.com/inward/record.url?scp=84914815582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914815582&partnerID=8YFLogxK

U2 - 10.1002/jps.24143

DO - 10.1002/jps.24143

M3 - Article

C2 - 25187109

AN - SCOPUS:84914815582

VL - 103

SP - 3542

EP - 3552

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 11

ER -